Tuberculosis, Cutaneous: Tuberculosis of the skin. It includes scrofuloderma and tuberculid, but not LUPUS VULGARIS.
Granulomatous disorders of skin and subcutaneous tissue
DOID EFO Endpoint Browser PheWeb
L12_GRANULOMATOUSSKIN
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
988 |
4. Check minimum number of eventsNone |
988 |
5. Include endpoints |
1017 |
6. Filter based on genotype QC (FinnGen only) |
985 |
Control definitions (FinnGen only)
- Control exclude
- L12_OTHERSKINSUBCUTIS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- L80-L99
- Name in latin
- Morbositates granulomatosae cutis et telae subcutaneae
Similar endpoints
↥List of similar endpoints to
Granulomatous disorders of skin and subcutaneous tissue
based on the number of shared cases.
Similar with more cases:
- Other disorders of skin and subcutaneous tissue
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 6497 | 4475 | 1996 |
| Only index persons | 6066 | 4239 | 1827 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.13 | 0.06 |
| Only index persons | 0.13 | 0.16 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 48.67 | 49.20 | 47.60 |
| Only index persons | 48.68 | 49.22 | 47.42 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 985 | 739 | 246 |
| Unadjusted period prevalence (%) | 0.22 | 0.26 | 0.11 |
| Median age at first event (years) | 50.40 | 47.90 | 57.91 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1017
- Matched controls
- 10170
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L92.0
ICD-10 Finland
Granuloma annulare
1334.6
307.7
557
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
13.4
295.2
330
352
L92.1
ICD-10 Finland
Necrobiosis lipoidica, not elsewhere classified
2471.0
226.8
211
*
L92.3
ICD-10 Finland
Foreign body granuloma of skin and subcutaneous tissue
613.2
113.3
110
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
9.0
110.4
146
185
A10AB01
ATC
insulin (human); parenteral
10.1
107.8
130
146
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
11.1
105.7
118
119
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
14.8
104.5
96
71
H04AA01
ATC
glucagon; nasal, parenteral
11.8
98.1
104
97
A10AB05
ATC
insulin aspart; parenteral
6.3
96.9
182
338
L30.9
ICD-10 Finland
Dermatitis, unspecified
3.9
87.6
360
1253
A10AC01
ATC
insulin (human); parenteral
5.6
84.6
180
374
A10AE04
ATC
insulin glargine; parenteral
5.2
84.2
201
462
L92.9
ICD-10 Finland
Granulomatous disorder of skin and subcutaneous tissue, unspecified
+∞
83.5
79
*
A10AE05
ATC
insulin detemir; parenteral
6.9
82.2
137
224
A10AB04
ATC
insulin lispro; parenteral
8.6
80.5
108
138
D07AD01
ATC
clobetasol; topical
4.0
79.9
295
947
T89
ICPC
Diabetes insulin dependent
7.3
78.6
124
191
A10AA01, ,
ATC
9.5
77.1
95
109
A10AA02, ,
ATC
8.9
75.5
98
120
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
39.2
73.0
45
12
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
10.6
71.9
81
82
D07AC01
ATC
betamethasone; topical
3.1
69.7
503
2418
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
21.9
69.4
52
25
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
17.7
69.1
57
34
H3603, E103,
ICD-10 Finland
26.5
69.0
48
19
XQ848
NOMESCO Finland
Dermatological photography
10.0
65.3
77
83
TQW80
NOMESCO Finland
Local dermatologic skincare
11.1
62.7
68
65
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
20.0
59.2
46
24
L92.8
ICD-10 Finland
Other granulomatous disorders of skin and subcutaneous tissue
+∞
58.9
56
*
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
17.1
58.5
49
30
A10AE06
ATC
insulin degludec; parenteral
6.8
58.1
95
151
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
25.1
57.8
41
17
E10
ICD-10 Finland
Type 1 diabetes mellitus
9.8
54.1
64
69
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.0
53.4
325
1381
103
Kela drug reimbursment
Diabetes, insulin-treated
2.9
51.2
335
1476
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
21.3
48.9
37
18
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
17.4
44.7
37
22
H3601, E103,
ICD-10 Finland
16.7
43.7
37
23
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
8.4
43.4
58
73
E0000UV, ,
ATC
2.5
43.4
523
3051
BEF00
NOMESCO Finland
Continuous subcutaneous glucose monitoring
16.2
41.9
36
23
H3600, E103,
ICD-10 Finland
11.8
41.6
43
38
CKC12
NOMESCO Finland
Photocoagulation of retina
5.7
40.6
78
145
SPAT1262
SPAT
Handing over of treatment supplies
2.9
39.9
231
939
H36.00
ICD-10 Finland
Diabetic background retinopathy
11.5
37.3
39
35
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
37.1
243
1050
D07AC13
ATC
mometasone; topical
2.4
36.2
373
1991
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
4.4
34.6
91
221
A10AD01
ATC
insulin (human); parenteral
7.7
34.6
49
66
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.2
32.8
70
143
S97
ICPC
Chronic ulcer skin
4.4
28.7
75
181
E10.8
ICD-10 Finland
Type 1 diabetes mellitus, With unspecified complications
7.9
27.3
38
50
J01FF01
ATC
clindamycin; systemic
2.2
26.1
315
1752
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
25.8
147
584
CL2S4
NOMESCO Finland
Ocular fundus photography for diabetic retinopathy screening
5.3
25.2
52
103
L92.2
ICD-10 Finland
Granuloma faciale [eosinophilic granuloma of skin]
+∞
25.1
24
*
H36.01
ICD-10 Finland
Diabetic maculopathy
8.9
24.6
31
36
A10AB06
ATC
insulin glulisine; parenteral
9.6
24.5
29
31
177
Kela drug reimbursment
Insulin glargine 300 U / ml
5.6
24.0
46
85
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
7.1
23.9
36
52
XCK10
NOMESCO Finland
Photography of fundus of eye
2.9
23.5
121
454
P01BA02
ATC
hydroxychloroquine; oral
2.9
23.4
116
427
E000001, ,
ATC
2.1
21.0
243
1316
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
30.8
20.6
27
9
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
18.8
20.5
31
17
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
20.3
123
502
J04BA02
ATC
dapsone; oral
33.3
20.3
26
8
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
3.2
20.2
86
289
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.7
19.8
116
465
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
5.4
19.8
39
74
127
Kela drug reimbursment
Transplant complication
7.9
19.6
27
35
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
5.2
19.4
40
79
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
6.6
19.3
31
48
J02AC01
ATC
fluconazole; systemic
1.8
19.2
472
3271
7094A
ICD-9 Finland
Other disorders of skin and subcutaneous tissue, Foreign body granuloma of skin and subcutaneous tissue
+∞
18.8
18
*
A46
ICD-10 Finland
Erysipelas
2.4
18.5
136
608
A10AA03, ,
ATC
8.0
18.3
25
32
XQ845
NOMESCO Finland
Dermatoscopy
6.8
17.9
28
42
H02AB06
ATC
prednisolone; systemic
1.8
17.9
483
3420
D07AB02
ATC
hydrocortisone butyrate; topical
1.9
17.8
327
2062
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
6.3
17.7
30
49
N03AX12
ATC
[U] gabapentin; oral
2.1
17.2
186
974
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.1
16.6
29
49
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
3.6
16.4
54
154
S29
ICPC
Skin symptom/complaint other
2.0
16.2
206
1144
S06
ICPC
Rash localized
3.1
16.1
70
238
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.9
15.8
244
1446
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
61.0
15.8
18
*
H43.1
ICD-10 Finland
Vitreous haemorrhage
4.9
15.7
35
74
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
15.2
424
2990
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.9
15.2
233
1377
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
15.1
291
1847
T90
ICPC
Diabetes non-insulin dependent
1.9
15.0
219
1271
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
4.6
14.8
35
78
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
2.8
14.7
77
291
J01MA02
ATC
ciprofloxacin; systemic
1.7
14.7
366
2497
Z94.0
ICD-10 Finland
Kidney transplant status
13.6
14.3
24
18
S18
ICPC
Laceration/cut
1.7
14.1
439
3170
TK800
NOMESCO Finland
Hemodialysis
5.9
14.0
25
43
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
14.0
214
1260
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
3.8
13.9
42
113
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.0
13.8
164
885
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
13.8
138
699
N02BE01
ATC
paracetamol; systemic, rectal
2.2
13.7
904
8003
J01DA01
ATC
[U] cefalexin
1.7
13.7
632
5035
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
6.6
13.7
22
34
L84
ICD-10 Finland
Corns and callosities
4.1
13.6
37
92
N02AX02
ATC
tramadol; systemic, rectal
1.7
13.6
407
2903
E10.4
ICD-10 Finland
Type 1 diabetes mellitus, With neurological complications
16.5
13.5
21
13
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.0
13.3
38
98
L04AA06
ATC
mycophenolic acid; systemic
5.5
13.1
25
46
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.1
13.1
132
670
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.6
13.1
76
303
D86.3
ICD-10 Finland
Sarcoidosis of skin
28.8
13.0
17
6
C03CA01
ATC
furosemide; systemic
1.8
12.7
239
1495
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
12.7
212
1280
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
15.7
12.6
20
13
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
6.1
12.6
22
37
C10AA01
ATC
simvastatin; oral
1.7
12.5
342
2369
SPAT1263
SPAT
Sampling
1.6
12.5
429
3147
C10AA05
ATC
atorvastatin; oral
1.7
12.5
355
2484
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.4
12.5
86
372
N18.8
ICD-10 Finland
Other chronic renal failure
5.1
12.5
26
52
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
38.0
12.2
15
*
OAB50, ,
SPAT
2.7
12.2
66
254
ZZA00
NOMESCO Finland
Split skin graft
4.2
12.1
32
78
UJF32
NOMESCO Finland
Coloscopy
1.8
12.1
243
1546
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
12.0
126
648
L43.8
ICD-10 Finland
Other lichen planus
5.1
12.0
25
50
N03AX16
ATC
[U] pregabalin
1.8
11.9
232
1462
M65.3
ICD-10 Finland
Trigger finger
2.8
11.9
60
222
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
11.9
152
840
A02BC02
ATC
pantoprazole; systemic
1.6
11.8
655
5364
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.3
11.7
97
455
M25.5
ICD-10 Finland
Pain in joint
1.6
11.7
339
2376
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
11.7
250
1618
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.7
11.6
65
254
QDA25
NOMESCO Finland
Destruction of lesion of skin of lower limb
23.2
11.6
16
7
ZXA10
NOMESCO Finland
Bilateral
1.8
11.5
183
1084
A10BK01
ATC
dapagliflozin; oral
2.5
11.5
72
298
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.1
11.4
49
166
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.0
11.3
127
670
NHQ40
NOMESCO Finland
Amputation of toe
12.9
11.2
19
15
H3602, E103,
ICD-10 Finland
25.3
11.2
15
6
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.1
11.1
109
547
XG410
NOMESCO Finland
Flow-volume spirometry
3.1
11.1
47
158
L60.0
ICD-10 Finland
Ingrowing nail
2.7
11.1
60
231
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.9
11.0
156
891
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
11.0
193
1179
171
Kela drug reimbursment
Degludekinsuliini
12.1
10.9
19
16
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
4.4
10.8
27
63
CKC15
NOMESCO Finland
Panretinal photocoagulation
10.7
10.8
20
19
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
10.8
76
332
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.5
10.7
70
296
L98.0
ICD-10 Finland
Pyogenic granuloma
60.6
10.6
12
*
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
5.3
10.6
21
40
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
4.3
10.6
27
64
E000003, ,
ATC
2.7
10.6
57
219
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.8
10.5
51
185
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
10.5
312
2191
J01AA02
ATC
doxycycline; systemic
1.6
10.4
758
6519
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
3.3
10.3
38
117
D02AE01
ATC
carbamide; topical
2.4
10.3
73
320
SPAT1153
SPAT
Removal of sutures
1.6
10.2
292
2027
A10BA02
ATC
metformin; oral
1.7
10.2
247
1644
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
2.9
10.2
49
177
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
10.2
62
253
A02BC01
ATC
omeprazole; systemic
1.6
10.2
265
1798
Z01.8
ICD-10 Finland
Other specified special examinations
1.7
10.1
220
1423
SPAT1255
SPAT
Intravenous administration of medicine
2.5
10.1
66
279
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
11.4
10.1
18
16
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.9
10.0
46
162
D02AX
ATC
Other emollients and protectives
3.2
10.0
40
130
205
Kela drug reimbursment
Chronic hypertension
1.7
9.9
201
1275
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
9.9
53
203
C09AA02
ATC
enalapril; systemic
1.8
9.8
157
930
R42
ICD-10 Finland
Dizziness and giddiness
1.7
9.8
214
1387
N06AX21
ATC
duloxetine; oral
1.9
9.7
134
757
D01AE15
ATC
terbinafine; topical
2.4
9.7
69
303
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.4
9.7
64
272
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.0
9.7
116
626
J01FA10
ATC
azithromycin; systemic
1.5
9.6
591
4844
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
2.9
9.5
43
150
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
9.5
250
1696
N03AE01
ATC
clonazepam; systemic
2.5
9.5
62
262
Z3229
NOMESCO Finland
Other healthcare associate professional
2.2
9.5
80
378
M04AA01
ATC
allopurinol; systemic
2.1
9.4
95
481
ZXC50
NOMESCO Finland
Cryotherapy
3.6
9.4
30
84
L92
ICD-10 Finland
Granulomatous disorders of skin and subcutaneous tissue
100.9
9.4
10
*
WXQ10
NOMESCO Finland
Psoralen - Ultraviolet A therapy with systemic sensitivisation
100.9
9.4
10
*
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
30.3
9.4
12
*
TQW99
NOMESCO Finland
Other minor procedure on skin
2.7
9.4
50
191
7098B
ICD-9 Finland
Other disorders of skin and subcutaneous tissue, Other specified disorders of skin[NECROBIOSIS LIPOIDICA]
+∞
9.4
9
*
J01DB01
ATC
cefalexin; oral
1.7
9.4
820
7259
XCH00
NOMESCO Finland
Eye pressure measurement
2.8
9.4
47
174
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.7
9.3
177
1102
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.6
9.3
268
1858
C07AB07
ATC
bisoprolol; oral
1.5
9.3
408
3109
M10.9
ICD-10 Finland
Gout, unspecified
2.6
9.3
52
204
Z3231
NOMESCO Finland
Registered nurse
1.6
9.2
256
1758
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
9.2
520
4174
WXQ12
NOMESCO Finland
Psoralen - Ultraviolet A therapy with local sensitivisation
13.8
9.2
15
11
L04AD02
ATC
tacrolimus; systemic
8.4
9.1
19
23
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
15.7
9.0
14
9
L89
ICD-10 Finland
Decubitus ulcer and pressure area
15.7
9.0
14
9
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.0
9.0
94
482
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.0
9.0
108
583
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.3
9.0
67
301
H02AB09
ATC
hydrocortisone; systemic
3.4
8.9
32
97
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
18.8
8.9
13
7
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
3.7
8.9
28
78
R06AE07
ATC
cetirizine; oral
1.5
8.9
447
3496
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
8.9
497
3972
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.1
8.8
80
389
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
3.5
8.8
30
88
ACC51
NOMESCO Finland
Release of median nerve
2.1
8.8
84
417
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
8.8
109
595
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
8.8
104
559
SPAT1229
SPAT
Assessment of need for aid
2.2
8.7
70
324
M01AE03
ATC
ketoprofen; systemic, rectal
1.5
8.7
337
2492
A10AD04
ATC
insulin lispro; parenteral
14.2
8.7
14
10
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
8.7
83
412
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
4.3
8.7
22
52
D07AB08
ATC
desonide; topical
1.9
8.7
111
612
M54.5
ICD-10 Finland
Low back pain
1.5
8.7
360
2702
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
3.8
8.7
26
70
CKD40
NOMESCO Finland
Endophotocoagulation of retina
4.4
8.6
21
48
S01
ICPC
Pain/tenderness of skin
2.7
8.6
47
182
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.9
8.6
107
585
V03AE01
ATC
polystyrene sulfonate; oral
9.1
8.5
17
19
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.8
8.5
148
897
N02BF01
ATC
gabapentin; oral
2.1
8.4
84
424
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.6
8.4
50
202
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.3
8.4
31
96
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.7
8.4
186
1206
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.2
8.3
70
331
E03.80
ICD-10 Finland
Hypothyroidism caused by autoimmune thyroiditis
3.2
8.3
32
102
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
8.3
304
2219
N06AA09
ATC
amitriptyline; systemic
2.0
8.2
98
527
WX002
NOMESCO Finland
Sedation and analgesia
1.7
8.2
174
1113
E000002, ,
ATC
1.9
8.2
114
645
S08
ICPC
Skin colour change
2.4
8.2
54
229
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
8.2
266
1888
A02BC05
ATC
esomeprazole; systemic
1.5
8.2
384
2947
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.1
8.2
33
108
H03AA01
ATC
levothyroxine sodium; systemic
1.6
8.2
244
1700
TNX30
NOMESCO Finland
Soft bandage, unspecified region
4.6
8.1
19
42
R01AD08
ATC
fluticasone; nasal
1.5
8.1
287
2075
L28
ICPC
Limited function/disability (L)
1.7
8.1
149
917
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.2
8.1
17
21
ZXA00
NOMESCO Finland
Right side
1.6
8.1
233
1609
A12AA04
ATC
calcium carbonate; oral
6.9
8.1
19
28
QDE99
NOMESCO Finland
Other excision or repair of lesion of skin of lower limb
11.8
8.1
14
12
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
8.1
248
1738
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
8.1
67
315
L91.0
ICD-10 Finland
Hypertrophic scar
10.1
8.0
15
15
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
8.0
392
3029
QDA99
NOMESCO Finland
Other local destruction of skin of lower limb
22.2
8.0
11
5
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
8.0
81
411
L17
ICPC
Foot/toe symptom/complaint
1.5
8.0
273
1959
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.4
8.0
53
226
C10AX09
ATC
ezetimibe; oral
1.8
8.0
131
781
R01AD09
ATC
mometasone; nasal
1.5
8.0
463
3700
SPAT1299
SPAT
Other function in accordance with podiatry nomenclature
4.5
7.9
19
43
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
13.1
7.9
13
10
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
7.8
396
3077
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
3.4
7.8
28
85
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.1
7.8
70
339
S20
ICPC
Corn/callosity
3.8
7.8
23
61
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.8
7.8
37
133
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.6
7.7
229
1590
WZC30
NOMESCO Finland
Teaching
1.7
7.7
141
866
A10BJ06
ATC
semaglutide; parenteral
2.4
7.7
52
224
R60.0
ICD-10 Finland
Localized oedema
1.9
7.7
107
607
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.1
7.6
72
356
L57.0
ICD-10 Finland
Actinic keratosis
2.0
7.6
82
426
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
3.6
7.6
24
67
R4180
NOMESCO Finland
Podiatric therapy
6.8
7.6
18
27
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.7
7.6
163
1046
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
25.2
7.6
10
*
RJ410, ,
NOMESCO Finland
25.2
7.6
10
*
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
3.4
7.6
26
77
137
Kela drug reimbursment
Uraemia requiring dialysis
10.1
7.5
14
14
L53.9
ICD-10 Finland
Erythematous condition, unspecified
4.5
7.4
18
41
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.4
184
1225
H36.09
ICD-10 Finland
Diabetic retinopathy (E10-E14+ with common fourth character .3)
13.5
7.4
12
9
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.7
7.4
38
143
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.7
7.4
127
767
R06AX22
ATC
ebastine; oral
1.6
7.4
177
1169
A02BC03
ATC
lansoprazole; oral
1.5
7.3
259
1867
A10BG03
ATC
pioglitazone; oral
3.5
7.3
24
69
XCD10
NOMESCO Finland
Electrophysiological examination of eye
3.3
7.3
27
84
M79.6
ICD-10 Finland
Pain in limb
1.4
7.3
403
3177
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
7.2
95
528
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.0
7.2
83
441
L70.0
ICD-10 Finland
Acne vulgaris
2.9
7.2
32
111
H02AB04
ATC
methylprednisolone; systemic
1.7
7.2
130
797
M03BX02
ATC
tizanidine; oral
1.4
7.2
606
5153
J01CA04
ATC
amoxicillin; systemic
1.6
7.1
819
7390
J01DA09
ATC
[U] cefadroxil
1.5
7.1
251
1808
M01AX01
ATC
nabumetone; oral
2.5
7.1
42
170
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.6
7.0
191
1298
SPAT1249
SPAT
Treatment-related counselling outside office
1.4
7.0
378
2960
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.0
218
1529
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
7.0
353
2730
L16
ICPC
Ankle symptom/complaint
1.8
7.0
113
671
L30.0
ICD-10 Finland
Nummular dermatitis
2.7
6.9
37
142
H01
ICPC
Ear pain/earache
1.7
6.9
124
757
CKC10
NOMESCO Finland
Local photocoagulation of retina
3.7
6.9
21
57
D09AB01
ATC
zinc bandage without supplements; topical
4.0
6.9
19
48
M01AB05
ATC
diclofenac; systemic, rectal
1.4
6.9
622
5332
Z96.4
ICD-10 Finland
Presence of endocrine implants
13.9
6.9
11
8
G63.2
ICD-10 Finland
Diabetic polyneuropathy
13.9
6.9
11
8
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.4
6.9
46
197
SPAT1301
SPAT
No procedures
1.5
6.9
286
2129
L01
ICPC
Neck symptom/complaint
1.6
6.8
159
1040
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
6.8
126
776
2501B
ICD-9 Finland
Diabetes mellitus, Diabetes with ketoacidosis[DIABETES MELLITUS CUM KETOACIDOSI ,TYYPPI I]
11.0
6.8
12
11
QCA25
NOMESCO Finland
Destruction of lesion of skin of upper limb
9.4
6.8
13
14
L93.0
ICD-10 Finland
Discoid lupus erythematosus
40.3
6.8
8
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
6.8
84
459
C08CA01
ATC
amlodipine; oral
1.5
6.7
301
2270
WX110
NOMESCO Finland
Infiltration anesthesia
1.4
6.7
698
6123
B01AA03
ATC
warfarin; systemic
1.7
6.7
126
779
XF402
NOMESCO Finland
ECG with work load test
1.9
6.7
88
489
RD210, ,
NOMESCO Finland
3.4
6.7
23
68
S99
ICPC
Skin disease other
3.3
6.7
24
73
G47.3
ICD-10 Finland
Sleep apnoea
1.6
6.7
188
1286
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
2.3
6.7
47
206
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.5
6.7
42
175
QCA99
NOMESCO Finland
Other local destruction of skin of upper limb
22.7
6.7
9
*
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
22.7
6.7
9
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.6
394
3130
L43.9
ICD-10 Finland
Lichen planus, unspecified
3.5
6.6
22
64
WX213
NOMESCO Finland
Lower leg blockade
8.8
6.6
13
15
L04AX01
ATC
azathioprine; systemic
2.4
6.6
44
189
J01MA12
ATC
levofloxacin; systemic
1.6
6.5
152
994
J05AB01
ATC
aciclovir; systemic
1.5
6.5
215
1523
D86.9
ICD-10 Finland
Sarcoidosis, unspecified
6.9
6.5
15
22
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.6
6.5
35
135
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
6.5
172
1160
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
6.5
116
1812
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.9
6.5
87
487
ZXA05
NOMESCO Finland
Left side
1.5
6.5
206
1448
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
2.3
6.5
47
209
WZC00
NOMESCO Finland
Treatment plan or consultation
1.4
6.5
335
2595
C07AB02
ATC
metoprolol; systemic
1.6
6.4
160
1065
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
3.8
6.4
19
51
L40.3
ICD-10 Finland
Pustulosis palmaris et plantaris
3.8
6.4
19
51
S11
ICPC
Skin infection post-traumatic
4.1
6.4
17
42
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.2
6.3
50
231
ZXC20
NOMESCO Finland
Use of chemical agents
3.5
6.3
21
61
QDH05
NOMESCO Finland
Correction of deformity of toe nail
18.1
6.3
9
5
L88
ICD-10 Finland
Pyoderma gangrenosum
+∞
6.3
6
*
B01AB05
ATC
enoxaparin; parenteral
1.5
6.3
272
2037
XW000
NOMESCO Finland
Bone marrow biopsy
2.5
6.2
37
150
CL2L4
NOMESCO Finland
Wide-field fundus photography for diabetic retinopathy screening
26.8
6.2
8
*
E27.1
ICD-10 Finland
Primary adrenocortical insufficiency
26.8
6.2
8
*
NH3CG
NOMESCO Finland
Extensive MRI of foot
7.1
6.2
14
20
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
6.2
163
1097
D01AC02
ATC
miconazole; topical
2.0
6.2
67
349
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.4
6.2
40
169
SBA00
NOMESCO Finland
Microbiological examinations
3.0
6.2
27
93
A11CC03
ATC
alfacalcidol; systemic
3.2
6.2
23
72
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.8
6.1
83
467
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.8
6.1
85
482
R51.80
ICD-10 Finland
Headache
1.6
6.1
162
1093
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
3.1
6.1
25
83
K10.3
ICD-10 Finland
Alveolitis of jaws
2.2
6.1
52
248
N08.39
ICD-10 Finland
Glomerular disorders in diabetes mellitus microalbuminuria
12.6
6.1
10
8
ZY010
NOMESCO Finland
Hospital outpatient
2.1
6.1
57
282
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
6.1
408
3299
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
2.3
6.1
44
196
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.9
6.0
28
100
B01AC04
ATC
clopidogrel; oral
1.7
6.0
112
691
L04AD01
ATC
ciclosporin; systemic
3.4
6.0
21
63
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
6.1
6.0
15
25
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
6.0
128
819
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
413
2225
2.44
40.09
5.7
3.8
17.39
8.67
mg/mmol
1.94
275
1351
391
2114
2.38
37.02
4.9
3.2
705.84
283.16
mg/l
0.73
261
1300
90
210
4.60
36.05
2.0
2.1
10.75
11.60
mg/l
0.43
85
193
416
2355
2.30
34.93
4.8
3.1
6.85
7.42
mmol/l
1.95
366
1997
113
342
3.59
31.64
2.0
2.0
40.61
38.76
u/l
0.37
105
303
568
3998
1.95
23.70
7.2
5.5
28.68
28.71
%
0.03
540
3755
563
3957
1.95
23.52
7.0
5.3
56.51
56.70
%
0.14
535
3709
641
4762
1.94
22.07
8.9
8.4
4.10
4.00
e9/l
0.61
566
4175
539
3816
1.88
21.17
9.7
6.0
1.22
1.22
mmol/l
0.04
472
3236
769
6148
2.03
20.50
5.3
3.9
12.66
11.34
mm/h
1.93
727
5696
475
3286
1.84
19.57
7.1
4.3
35.47
36.09
g/l
1.56
438
3055
381
2474
1.86
19.14
3.6
2.4
55.63
61.25
u/l
1.04
354
2276
498
3552
1.79
18.06
3.0
2.3
76.78
76.52
nmol/l
0.07
465
3202
334
2115
1.86
17.93
1.5
1.3
2.14
1.72
u/ml
0.21
103
548
470
3308
1.78
17.73
19.2
11.9
1.29
1.20
inr
1.13
149
987
771
6299
1.93
17.53
9.1
6.7
78.95
76.45
u/l
1.05
736
5890
180
939
2.11
16.82
11.8
4.6
1.09
1.05
mmol/l
1.36
171
860
551
4114
1.74
16.47
6.1
5.7
10.36
10.86
umol/l
0.36
522
3886
55
160
3.58
16.25
2.7
2.2
165.14
83.57
ug/min
0.82
43
98
597
4597
1.72
15.61
6.1
4.3
7.76
6.54
mmol/l
13.37
557
4225
126
593
2.28
15.13
5.5
3.6
96.98
75.08
ng/l
1.75
110
527
440
3146
1.70
14.90
2.2
1.9
100.52
96.40
pmol/l
0.98
247
1611
122
572
2.29
14.78
2.3
2.4
19.06
24.43
au/ml
—
7
46
336
2240
1.75
14.61
2.3
2.0
143.95
250.42
u/l
1.58
323
2108
298
1936
1.76
14.09
3.4
2.3
2805.34
5761.07
umol/l
0.82
270
1699
246
1521
1.81
13.71
1.3
1.3
18.49
30.64
iu/ml
2.74
77
487
468
3455
1.66
13.67
8.2
5.5
1.22
1.22
mmol/l
0.09
436
3146
143
740
2.08
13.50
2.4
2.0
384.77
374.77
nmol/l
0.25
132
682
236
1468
1.79
12.79
1.3
1.3
9.83
11.90
u/ml
0.19
93
559
301
2013
1.70
12.60
2.6
2.1
2.81
2.94
mg/l
0.45
274
1712
142
752
2.03
12.56
6.3
4.0
240.21
250.96
u/l
0.28
133
716
275
1801
1.72
12.40
1.6
1.5
2.29
2.25
g/l
0.12
159
1082
121
619
2.08
11.73
5.6
3.4
1.82
2.00
mmol/l
0.24
103
501
894
7983
1.99
11.68
6.3
4.9
1.87
1.84
mu/l
0.23
848
7375
59
220
2.79
11.56
1.2
1.2
2.16
9.96
u/ml
—
7
37
855
7537
1.84
11.46
8.6
5.1
45.00
39.06
mmol/mol
26.50
811
7011
791
6825
1.72
11.36
5.1
4.1
14.75
14.61
pmol/l
0.81
743
6242
178
1059
1.83
11.04
3.8
2.1
2.34
2.40
g/l
0.77
168
973
167
979
1.84
10.86
3.7
2.2
22.76
22.76
%
0.00
137
843
935
8547
2.17
10.49
21.1
13.2
139.30
139.64
mmol/l
4.33
916
8302
375
2754
1.57
10.38
3.5
3.0
29.75
30.26
u/l
0.15
355
2612
90
433
2.18
10.20
5.4
3.6
0.38
1.83
mmol/l
2.75
71
317
61
247
2.56
10.19
1.5
1.6
150.06
0.10
iu/ml
0.47
14
39
51
190
2.77
10.03
3.2
3.0
—
—
—
0
0
188
1168
1.75
10.01
3.7
2.1
13.01
13.35
umol/l
0.29
177
1081
935
8573
2.12
9.98
21.5
13.3
3.98
3.94
mmol/l
3.64
914
8305
926
8463
2.05
9.93
19.6
11.8
20.58
21.32
mg/l
0.30
794
6558
41
136
3.10
9.90
10.6
4.7
452.86
241.94
iu/ml
—
7
16
188
1173
1.74
9.85
4.9
3.1
0.81
0.82
mmol/l
0.74
182
1108
310
2210
1.58
9.61
1.9
1.6
1.37
1.35
mmol/l
0.16
265
1884
375
2792
1.54
9.59
3.9
3.3
36.24
45.75
ng/l
0.27
245
1756
104
542
2.02
9.56
3.4
2.8
67.36
67.35
g/l
0.00
94
493
99
507
2.06
9.55
1.9
1.5
—
—
—
0
0
184
1151
1.73
9.54
2.3
1.7
—
—
—
0
0
29
80
3.70
9.32
1.1
1.2
—
—
—
0
0
134
769
1.86
9.27
3.2
2.6
1.95
1.81
%
0.79
122
686
44
161
2.81
8.97
1.6
1.3
257.48
226.10
u/ml
0.34
27
99
515
4154
1.49
8.72
4.5
3.4
0.00
0.00
estimate
0.99
100
828
202
1330
1.65
8.58
1.9
1.7
1231.00
1195.21
nmol/l
0.21
166
995
12
6
20.21
8.48
9.5
5.3
—
—
—
0
0
53
220
2.49
8.44
1.5
1.4
288.58
312.84
ug/g
0.46
31
115
108
596
1.91
8.42
2.7
2.7
10.90
10.39
g/l
0.61
98
544
495
3981
1.47
8.39
3.9
2.7
102.75
94.07
ug/l
0.45
461
3698
44
167
2.71
8.38
1.6
1.3
—
—
—
0
0
519
4218
1.47
8.30
4.5
3.4
0.00
0.00
estimate
0.50
85
761
24
64
3.82
8.10
1.3
1.1
—
68.00
—
0
7
173
1120
1.66
7.80
2.2
2.3
151.10
108.48
ug/g
0.55
127
871
511
4176
1.45
7.74
6.1
4.6
0.00
0.00
estimate
0.50
96
782
36
129
2.86
7.65
1.1
1.2
—
—
—
0
0
350
2690
1.46
7.19
4.0
3.2
2.34
2.35
mmol/l
0.91
310
2395
94
533
1.84
6.74
3.4
2.8
134.54
166.99
ng/l
0.62
85
486
111
662
1.76
6.74
1.9
2.2
0.22
0.22
g/l
0.20
100
619
262
1932
1.48
6.56
3.3
2.9
1083.82
982.12
ng/l
0.28
229
1599
38
153
2.54
6.50
2.2
1.7
—
—
—
0
0
57
277
2.12
6.36
4.9
7.0
1.65
1.56
%
0.33
57
259
954
9019
1.93
6.14
13.5
9.3
25.83
24.96
u/l
0.91
931
8702
31
116
2.72
6.13
1.4
1.2
—
—
—
0
0
642
5596
1.40
6.08
5.9
4.2
50.00
2299.45
e6/l
—
9
82
53
256
2.13
6.01
1.4
1.7
—
—
—
0
0
227
1654
1.48
5.98
1.9
1.7
117277933.03
31522952.92
pmol/l
0.60
191
1399
53
260
2.10
5.79
2.1
1.6
—
—
—
0
0
161
1101
1.55
5.71
3.9
2.0
30.41
29.31
s
1.25
153
1069
15
27
5.62
5.69
1.1
1.0
—
—
—
0
0
27
98
2.80
5.66
1.7
1.4
—
—
—
0
0
56
284
2.03
5.61
2.6
1.7
—
—
—
0
0
34
145
2.39
5.20
2.3
1.4
102.30
108.64
u/ml
—
10
29
27
103
2.67
5.18
1.5
1.3
—
—
—
0
0
30
122
2.50
5.08
2.0
1.4
—
—
—
0
0
30
122
2.50
5.08
2.0
1.4
—
—
—
0
0
122
805
1.59
5.05
2.1
1.6
—
—
—
0
0
29
118
2.50
4.91
1.8
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
182
2.19
4.87
2.7
3.2
0.35
0.39
u/ml
0.31
22
95
39
183
2.18
4.81
1.2
1.2
28.52
35.59
u/ml
—
5
16
855
7955
1.47
4.78
4.8
3.6
1.38
1.26
mmol/l
3.74
805
7346
390
3222
1.34
4.77
4.8
3.5
—
—
—
0
0
17
52
3.31
4.76
2.2
2.2
680.08
560.97
ml
0.57
12
33
121
808
1.56
4.76
2.1
1.7
—
—
—
0
0
32
139
2.34
4.72
1.1
1.1
155.11
112.37
iu/ml
—
9
30
38
179
2.17
4.65
2.2
1.5
—
—
—
0
0
31
134
2.35
4.63
1.7
1.4
—
—
—
0
0
72
424
1.75
4.61
8.5
8.2
24.63
24.60
mmol/l
0.02
72
402
37
174
2.17
4.55
2.2
1.5
—
—
—
0
0
18
59
3.09
4.53
4.2
2.6
—
—
—
0
0
38
181
2.14
4.53
1.5
1.1
—
—
—
0
0
885
8314
1.50
4.48
5.4
4.1
4.60
4.75
mmol/l
4.35
849
7763
35
162
2.20
4.48
2.7
2.2
125.22
129.20
g/l
0.31
23
120
21
76
2.80
4.47
1.4
1.1
52.90
50.89
u/l
0.12
21
70
47
852
0.53
4.46
1.7
1.6
—
—
—
0
0
234
1801
1.39
4.45
1.8
1.5
20.56
21.63
nmol/l
0.50
203
1544
60
339
1.82
4.42
5.0
3.4
24.06
24.11
mmol/l
0.04
60
330
465
3972
1.31
4.40
3.2
2.4
—
—
—
0
0
7
6
11.73
4.28
1.4
4.5
—
—
—
0
0
25
102
2.49
4.24
4.3
3.0
1.18
1.15
%
0.03
25
93
113
765
1.54
4.19
7.0
8.1
1.45
1.16
mmol/l
0.42
92
616
184
1379
1.41
4.07
4.3
3.4
208.16
356.61
ng/l
0.80
134
971
289
2329
1.34
4.06
4.9
2.9
45.20
76.80
e6/l
0.50
223
1783
878
8278
1.44
3.93
5.3
4.0
1.44
1.51
mmol/l
5.59
828
7701
38
192
2.02
3.92
1.9
1.6
—
—
—
0
0
104
702
1.54
3.92
1.2
1.2
117.41
142.48
iu/ml
0.44
55
281
862
8106
1.42
3.86
5.0
4.2
6.47
5.82
mmol/l
16.90
795
7445
633
5694
1.30
3.84
3.6
2.9
46.86
42.04
u/l
0.88
594
5347
95
634
1.55
3.77
8.0
8.7
117.97
120.64
g/l
0.62
95
617
6
5
12.06
3.76
1.7
6.4
—
—
—
0
0
892
8448
1.45
3.76
5.9
4.5
2.68
2.82
mmol/l
4.56
836
7856
238
1886
1.34
3.71
2.5
1.7
1.18
1.09
mg/l
0.20
181
1417
127
906
1.46
3.67
2.9
2.5
6.47
6.72
umol/l
0.06
108
767
167
1254
1.40
3.64
3.1
2.5
1.10
0.99
e6/l
0.15
98
691
13
35
3.75
3.60
1.1
1.5
—
24.80
—
0
5
658
5979
1.28
3.54
3.3
3.3
—
—
—
0
0
20
81
2.50
3.48
2.2
1.4
—
—
—
0
0
33
166
2.02
3.47
1.8
1.8
7396.92
16207.46
e6/l
0.86
26
127
37
194
1.94
3.47
1.5
1.4
—
—
—
0
0
81
532
1.57
3.46
2.4
2.3
5.45
6.87
ug/l
0.56
74
464
93
634
1.51
3.37
6.5
3.3
1.23
1.23
mmol/l
0.53
80
543
842
7933
1.36
3.33
16.2
10.9
82.49
84.99
ml/min/173m2
2.29
709
6413
19
77
2.50
3.31
7.9
6.2
12.65
11.49
mg/l
0.64
19
71
14
48
2.94
3.31
1.0
1.2
—
—
—
0
0
205
1620
1.33
3.23
4.2
2.3
4.84
7.41
e6/l
2.85
185
1455
14
49
2.88
3.20
1.5
1.3
95411.25
54004.12
e6/l
—
8
25
85
577
1.52
3.15
1.3
1.2
129.93
232.43
u/ml
1.14
78
536
17
67
2.56
3.13
1.2
1.3
—
—
—
0
0
981
9538
1.81
3.11
27.7
17.8
263.41
257.13
e9/l
2.14
972
9294
12
35
3.46
3.11
2.7
1.6
—
—
—
0
0
12
35
3.46
3.11
2.8
1.6
—
—
—
0
0
43
247
1.77
3.08
2.9
1.9
—
—
—
0
0
33
174
1.93
3.08
7.0
2.2
0.96
0.89
nmol/l
0.18
28
144
154
1176
1.36
3.03
3.7
2.7
3.95
3.46
e6/l
0.22
88
619
981
9544
1.79
3.02
27.7
17.7
4.44
4.48
e12/l
1.43
968
9283
980
9532
1.77
3.01
27.8
17.8
39.51
39.95
%
1.32
918
8945
72
478
1.54
2.97
1.7
2.2
11482.64
5059.68
u/l
0.75
24
206
981
9547
1.78
2.97
27.8
17.9
133.18
134.30
g/l
1.76
975
9410
17
69
2.49
2.97
1.2
1.0
—
—
—
0
0
257
2118
1.29
2.96
4.6
2.8
0.21
0.42
e6/l
2.90
188
1594
15
58
2.61
2.88
2.2
1.3
2485.90
1712.50
e6/l
—
10
38
19
83
2.31
2.85
1.8
2.5
4.07
4.05
mmol/l
0.07
19
83
19
83
2.31
2.85
1.8
2.5
105.68
105.81
mmol/l
0.04
19
83
242
1989
1.28
2.84
5.1
3.4
96.06
94.14
%
0.53
235
1924
13
47
2.79
2.82
2.3
1.4
—
—
—
0
0
11
33
3.36
2.81
1.1
1.1
14.82
31.09
u/l
1.02
11
33
11
33
3.36
2.81
1.1
1.1
75.82
92.27
u/l
0.42
11
33
16
65
2.48
2.80
2.7
1.5
—
—
—
0
0
16
65
2.48
2.80
2.7
1.5
—
—
—
0
0
16
65
2.48
2.80
2.7
1.5
—
—
—
0
0
10
29
3.47
2.69
3.7
1.8
—
—
—
0
0
10
29
3.47
2.69
3.7
1.8
—
—
—
0
0
34
190
1.82
2.69
3.4
3.7
25.13
28.73
mg/l
0.44
27
151
34
190
1.82
2.69
3.4
3.7
59.64
83.47
mg/l
0.28
27
152
25
126
2.01
2.67
1.4
1.4
—
—
—
0
0
25
126
2.01
2.67
1.4
1.7
—
—
—
0
0
176
1404
1.31
2.58
2.7
2.7
2.45
2.44
mmol/l
0.41
148
1241
9
25
3.62
2.58
2.8
1.7
—
—
—
0
0
9
25
3.62
2.58
2.8
1.7
—
—
—
0
0
9
25
3.62
2.58
1.2
1.1
—
—
—
0
0
221
1820
1.27
2.54
4.7
3.7
1.02
1.02
kg/l
0.50
45
254
9
26
3.48
2.48
2.8
1.7
—
—
—
0
0
12
45
2.69
2.45
1.6
1.1
25.00
15.00
u/l
0.35
12
39
26
138
1.91
2.43
1.0
1.0
6.16
2.46
u/ml
—
8
62
11
38
2.91
2.42
1.1
1.3
—
90.00
—
0
8
29
160
1.84
2.41
7.1
10.1
103.00
105.37
mmol/l
1.11
29
145
12
46
2.63
2.36
2.5
2.0
—
—
—
0
0
24
126
1.93
2.32
2.7
1.5
—
—
—
0
0
12
47
2.57
2.27
1.6
1.1
121.25
75.93
u/l
0.59
12
41
13
54
2.43
2.20
1.3
1.4
—
—
—
0
0
18
87
2.09
2.18
1.4
1.4
—
—
—
0
0
18
87
2.09
2.18
1.4
1.4
—
—
—
0
0
28
159
1.78
2.15
5.4
3.7
52.36
57.81
%
1.55
28
159
29
167
1.76
2.13
1.5
1.3
—
—
—
0
0
20
102
1.98
2.11
2.0
1.5
—
—
—
0
0
225
1900
1.24
2.06
1.7
1.6
—
—
—
0
0
125
985
1.31
2.02
5.0
4.1
32.43
32.30
%
0.05
99
673
230
1951
1.23
2.02
2.8
2.1
—
—
—
0
0
15
70
2.16
1.99
2.5
1.5
—
—
—
0
0
78
575
1.39
1.96
3.6
3.3
4.60
4.55
pmol/l
0.11
71
515
101
779
1.33
1.91
3.6
3.0
—
—
—
0
0
57
401
1.45
1.87
2.2
1.6
—
—
—
0
0
8
28
2.87
1.86
1.3
1.6
140.69
53.76
ug/l
—
8
28
22
123
1.81
1.81
1.0
1.1
—
—
—
0
0
26
153
1.72
1.81
4.8
3.6
3.67
4.22
e9/l
0.85
26
153
18
94
1.93
1.81
1.8
2.3
23.20
22.64
mg/l
—
5
27
24
138
1.76
1.80
3.3
2.1
16.67
16.07
%
0.24
16
65
13
60
2.18
1.78
2.2
1.2
6.41
6.17
mmol/l
0.10
13
53
49
343
1.45
1.67
1.3
1.3
174.91
239.76
miu/ml
0.60
21
174
78
593
1.34
1.65
2.5
2.3
65.42
71.11
ml/min/173m2
0.52
43
240
28
173
1.64
1.65
1.4
1.2
20.77
9.23
e6/l
0.25
22
137
28
173
1.64
1.65
1.4
1.3
9242.00
1012.59
e6/l
0.42
22
141
10
43
2.34
1.59
1.1
1.2
—
—
—
0
0
12
57
2.12
1.55
1.2
1.5
—
—
—
0
0
5
15
3.34
1.52
1.6
1.3
-1.08
2.73
mmol/l
—
5
15
785
7535
1.18
1.47
22.0
14.4
15.19
14.66
%
1.50
773
7404
16
88
1.83
1.42
2.1
1.7
32.19
32.07
pg
0.03
16
88
252
2227
1.17
1.41
5.4
3.7
0.00
0.01
estimate
1.08
88
764
25
158
1.60
1.38
2.4
2.5
4.30
6.26
umol/l
0.53
16
115
9
41
2.21
1.37
2.9
1.4
—
—
—
0
0
19
112
1.71
1.36
2.0
1.6
1.27
1.65
mmol/l
1.87
19
112
20
120
1.68
1.35
1.4
1.1
—
—
—
0
0
9
42
2.15
1.34
2.9
1.4
—
—
—
0
0
52
386
1.37
1.32
1.3
1.7
2.96
4.61
mg/l
0.44
40
279
22
137
1.62
1.30
1.3
1.3
—
—
—
0
0
22
137
1.62
1.30
1.3
1.3
—
—
—
0
0
8
34
2.36
1.29
2.1
2.8
36496.38
37600.00
ug/l
—
8
34
5
18
2.79
1.28
1.2
1.1
—
—
—
0
0
9
44
2.05
1.27
1.1
1.0
—
—
—
0
0
89
722
1.26
1.21
3.0
4.2
7.65
28.37
ug/l
1.04
73
595
5
19
2.64
1.21
3.6
2.2
—
—
—
0
0
8
37
2.17
1.21
1.1
1.2
—
—
—
0
0
8
38
2.11
1.18
1.1
1.2
—
—
—
0
0
12
64
1.89
1.18
1.6
1.5
248304.29
103999.70
e6/l
—
7
44
37
266
1.41
1.16
1.3
1.3
—
—
—
0
0
5
20
2.51
1.15
1.0
1.1
—
—
—
0
0
34
243
1.41
1.11
5.9
3.9
1.43
1.32
mmol/l
0.31
34
238
7
31
2.27
1.10
1.1
1.1
—
—
—
0
0
88
723
1.24
1.09
3.4
2.3
33.08
36.80
u/l
0.25
73
604
34
244
1.41
1.09
1.9
1.9
3.02
5.04
iu/l
1.46
16
91
56
436
1.30
1.08
1.4
1.4
—
—
—
0
0
13
74
1.77
1.07
2.7
3.1
—
—
—
0
0
17
106
1.61
1.03
2.4
1.4
—
—
—
0
0
32
230
1.40
1.02
6.3
2.4
214.56
178.89
%
1.04
32
223
29
400
0.72
0.98
1.4
1.4
—
—
—
0
0
29
399
0.72
0.97
1.4
1.4
—
—
—
0
0
16
100
1.61
0.97
1.4
1.3
—
—
—
0
0
29
398
0.72
0.96
1.4
1.4
—
—
—
0
0
14
85
1.66
0.94
1.6
1.7
22.25
59.83
%
—
8
60
6
27
2.23
0.93
1.2
1.4
—
—
—
0
0
11
184
0.59
0.93
1.6
1.6
—
—
—
0
0
9
52
1.74
0.92
2.1
1.3
20.30
7.38
u/l
—
9
42
6
28
2.15
0.91
1.3
1.4
—
—
—
0
0
16
102
1.58
0.91
1.4
1.3
—
—
—
0
0
12
71
1.70
0.89
2.3
1.7
—
—
—
0
0
6
30
2.01
0.87
1.3
1.5
—
—
—
0
0
34
256
1.34
0.85
1.3
1.2
—
—
—
0
0
6
31
1.94
0.84
1.3
1.4
—
—
—
0
0
30
399
0.74
0.84
1.4
1.4
—
—
—
0
0
22
154
1.44
0.84
1.4
1.4
24.08
22.83
u/l
0.07
17
130
12
73
1.65
0.82
1.4
1.9
40.08
20.92
ug/l
0.33
12
73
15
98
1.54
0.78
2.3
2.2
—
—
—
0
0
24
174
1.39
0.77
3.0
3.5
30.34
27.14
mg/l
0.17
14
107
15
99
1.52
0.76
1.5
1.3
—
—
—
0
0
15
99
1.52
0.76
1.5
1.3
—
—
—
0
0
11
67
1.65
0.75
1.6
1.3
—
—
—
0
0
33
254
1.31
0.74
1.2
1.2
—
—
—
0
0
15
100
1.51
0.73
1.5
1.3
—
—
—
0
0
34
433
0.78
0.72
1.4
1.5
—
—
—
0
0
7
41
1.71
0.70
2.7
3.2
—
—
—
0
0
15
102
1.48
0.67
1.5
1.3
—
—
—
0
0
34
268
1.28
0.66
2.7
3.2
15.89
1088.01
u/ml
1.14
28
229
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
45
369
1.23
0.63
1.5
1.4
—
—
—
0
0
19
138
1.38
0.62
1.4
1.2
4.20
5.53
u/ml
—
10
49
12
79
1.53
0.62
2.5
1.5
—
—
—
0
0
27
345
0.78
0.61
1.4
1.5
—
—
—
0
0
71
820
0.86
0.60
3.1
2.9
0.77
0.75
ug/l
0.08
50
511
154
1401
1.12
0.60
4.5
4.7
1.76
2.39
ug/l
1.43
140
1252
135
1220
1.12
0.60
2.1
2.0
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
12
173
0.69
0.58
1.2
1.1
—
—
—
0
0
6
35
1.72
0.57
1.5
1.1
0.33
0.30
g/l
—
6
29
6
35
1.72
0.57
1.3
1.2
—
70.60
%
—
0
5
6
35
1.72
0.57
1.2
1.1
110.67
112.93
%
—
6
29
103
920
1.13
0.56
8.6
5.9
—
—
—
0
0
6
37
1.63
0.55
1.2
1.1
547.33
141.06
iu/ml
—
6
37
35
285
1.24
0.54
1.7
1.8
—
—
—
0
0
9
60
1.50
0.54
3.0
1.6
—
—
—
0
0
149
1363
1.11
0.54
2.1
2.1
—
—
—
0
0
9
61
1.48
0.53
1.1
1.0
—
—
—
0
0
6
39
1.54
0.53
3.5
1.7
—
1130710.00
—
0
5
6
40
1.50
0.51
2.0
1.1
141.17
523.44
u/l
—
6
34
6
40
1.50
0.51
1.2
1.1
1117.33
1651.33
miu/ml
—
6
40
9
64
1.41
0.51
3.0
2.0
—
—
—
0
0
59
511
1.16
0.50
1.4
1.4
—
—
—
0
0
7
45
1.56
0.49
1.4
1.2
—
—
—
0
0
18
137
1.32
0.47
1.2
1.3
—
—
—
0
0
112
1021
1.11
0.45
1.6
1.7
1.48
1.40
%
0.57
94
911
32
265
1.21
0.45
1.1
1.4
11.08
9.73
u/l
0.16
23
216
13
95
1.37
0.44
1.4
1.1
92.31
95.26
%
0.13
13
89
64
719
0.88
0.41
1.4
1.5
—
—
—
0
0
59
521
1.14
0.41
1.0
1.0
—
—
—
0
0
0
17
0.00
0.40
0.0
1.5
—
0.12
—
0
11
5
34
1.47
0.40
1.0
1.0
—
—
—
0
0
5
35
1.43
0.39
1.0
1.0
1081.80
673.36
ng/l
—
5
22
5
35
1.43
0.39
1.0
1.0
260.80
311.32
ng/l
—
5
22
6
43
1.40
0.35
1.2
1.1
—
—
—
0
0
26
308
0.84
0.34
1.6
1.7
—
—
—
0
0
12
91
1.32
0.34
1.0
1.1
—
—
—
0
0
6
46
1.31
0.33
2.0
1.4
—
—
—
0
0
30
257
1.17
0.32
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
47
1.28
0.32
1.2
1.1
—
—
—
0
0
56
504
1.12
0.31
1.4
1.4
22.53
26.75
iu/l
0.49
47
427
7
53
1.32
0.31
1.3
1.3
64.00
72.58
umol/l
—
7
53
40
353
1.14
0.30
2.1
1.7
—
—
—
0
0
7
55
1.27
0.30
2.9
1.9
—
—
—
0
0
16
195
0.82
0.29
1.2
1.1
0.41
3.53
u/ml
—
9
110
7
57
1.23
0.29
1.1
1.2
—
—
—
0
0
19
158
1.21
0.28
1.8
1.8
—
—
—
0
0
8
65
1.23
0.27
1.3
1.3
—
—
—
0
0
8
66
1.21
0.26
1.3
1.3
—
—
—
0
0
11
86
1.28
0.26
1.3
1.1
—
—
—
0
0
43
476
0.90
0.25
1.2
1.4
—
—
—
0
0
16
133
1.21
0.24
1.1
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
66.93
—
0
12
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
10
81
1.24
0.18
1.0
1.1
—
—
—
0
0
14
164
0.85
0.18
1.1
1.0
0.64
1.98
u/ml
—
7
83
16
138
1.16
0.17
1.5
1.2
2.62
4.20
u/ml
—
8
61
7
62
1.13
0.17
1.3
1.3
—
—
—
0
0
5
67
0.75
0.17
1.0
1.1
—
—
—
0
0
15
130
1.16
0.15
1.3
1.1
—
—
—
0
0
36
390
0.92
0.15
1.3
1.4
—
—
—
0
0
184
1891
0.97
0.14
1.6
1.4
—
—
—
0
0
116
1118
1.04
0.14
4.4
4.2
23.96
21.36
%
0.76
47
509
10
86
1.16
0.11
1.6
1.5
—
—
—
0
0
87
841
1.04
0.10
1.9
1.9
—
—
—
0
0
5
44
1.14
0.10
1.0
1.4
182.34
166.14
pmol/l
—
5
44
39
412
0.94
0.10
1.3
1.5
258.85
290.07
mu/l
0.58
33
368
68
656
1.04
0.09
1.9
1.8
—
—
—
0
0
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
25
235
1.07
0.07
1.2
1.1
—
—
—
0
0
9
86
1.05
0.07
1.0
1.1
—
—
—
0
0
9
87
1.03
0.07
1.0
1.1
—
—
—
0
0
23
218
1.06
0.05
1.4
1.3
—
—
—
0
0
10
110
0.91
0.05
1.3
1.3
0.60
0.60
nmol/l
—
10
105
35
337
1.04
0.05
2.1
1.8
—
—
—
0
0
12
130
0.92
0.04
3.5
3.9
23.28
2160.11
u/ml
0.61
12
124
26
249
1.05
0.04
1.4
1.3
—
—
—
0
0
13
132
0.98
0.00
5.8
5.4
332.27
369.99
umol/l
0.43
13
113
10
103
0.97
0.00
1.2
1.7
7.05
7.59
mmol/l
—
10
98
17
173
0.98
0.00
1.4
1.5
0.34
0.38
nmol/l
0.18
11
140
0
5
0.00
0.00
0.0
1.4
—
98.00
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
20.68
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.8
—
6.16
—
0
5
0
5
0.00
0.00
0.0
1.0
—
7.80
—
0
5
0
5
0.00
0.00
0.0
1.0
—
38.20
—
0
5
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
6.68
—
0
6
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
7
72
0.97
-0.00
1.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
8.8
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.2
—
—
—
0
0
7
73
0.96
-0.00
1.0
1.2
—
—
—
0
0
7
72
0.97
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint L12_GRANULOMATOUSSKIN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_GRANULOMATOUSSKIN | 1.145 [1.0, 1.32] | 0.059 |
| Birth year | 0.999 [0.99, 1.01] | 0.746 |
During the follow-up period (1.1.1998 — 31.12.2019), 354 out of 3770 females with L12_GRANULOMATOUSSKIN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| L12_GRANULOMATOUSSKIN | 1.461 [1.22, 1.75] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 267 out of 1645 males with L12_GRANULOMATOUSSKIN died.
Mortality risk
Mortality risk for people of age
years, who have L12_GRANULOMATOUSSKIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.143% | 0.267% |
| 5 | 0.787% | 1.629% |
| 10 | 1.85% | 4.028% |
| 15 | 3.655% | 7.592% |
| 20 | 6.152% | 13.196% |
Relationships between endpoints
↥Index endpoint: L12_GRANULOMATOUSSKIN – Granulomatous disorders of skin and subcutaneous tissue
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data